Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128932) titled 'Antiviral Treatment Strategies to Improve the Clinical Cure Rate and Reduce the Relapse Rate of Chronic Hepatitis B' on July 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Chronic Hepatitis B (CHB)
Intervention:
Conventional Hepatitis B Vaccine Group:Conventional Hepatitis B Vaccine Vaccination
Novel Dual-Adjuvant Hepatitis B Vaccine Group:Dual-Adjuvant Hepatitis B Vaccine Vaccination
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Conventional Hepatitis B Vaccine Group:4...